FATE THERAPEUTICS INC
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | $12.4M | $160.5M | $190.5M |
| FY2019 | — | $244.8M | $99.8M |
| FY2020 | — | $384.4M | $167.3M |
| FY2021 | — | $678.8M | $133.6M |
| FY2022 | — | $483.9M | $61.3M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | $12.4M | $160.5M | $190.5M |
| FY2019 | — | $244.8M | $99.8M |
| FY2020 | — | $384.4M | $167.3M |
| FY2021 | — | $678.8M | $133.6M |
| FY2022 | — | $483.9M | $61.3M |